Clinical and Lab Diagnostics - New method provides a more accurate way to predict dementia up to nine years before diagnosis
Can't see this email? View it online
   
  Clinical and Lab Diagnostics Clinical and Lab Diagnostics logo  
  The latest clinical and lab diagnostics news from News Medical  
 

Ensuring Dosing Accuracy: Overcoming Challenges with Analytical BalancesEnsuring Dosing Accuracy: Overcoming Challenges with Analytical Balances

Accurate medication dosages are crucial for patient safety, particularly in the context of infusion pumps where precision is critical. This application note outlines the requirements and challenges of testing dosing accuracy according to IEC 60601-2-24 and AAMI TIR-101. Leveraging Cubis® II balances, in collaboration with B.Braun, Sartorius explore common sources of errors, highlighting the critical role of high-precision balances in ensuring reliable medication delivery in medical settings.

Read the Application Note
 
   New method provides a more accurate way to predict dementia up to nine years before diagnosisNew method provides a more accurate way to predict dementia up to nine years before diagnosis
 
Researchers at Queen Mary University of London have developed a new method for predicting dementia with over 80% accuracy and up to nine years before a diagnosis.
 
   Abdominal pain and hematochezia could be crucial red flags for early-onset colorectal cancerAbdominal pain and hematochezia could be crucial red flags for early-onset colorectal cancer
 
The study identifies key symptoms like abdominal pain and hematochezia as significant indicators of early-onset colorectal cancer and stresses the importance of early diagnosis to improve survival rates.
 
 5-Cog paradigm: A breakthrough in dementia diagnosis and care
 
5-Cog paradigm: A breakthrough in dementia diagnosis and careThe underdiagnosis of dementia, especially among Black and Hispanic patients, is a long-standing challenge in medicine.
 
 
 Delayed multiple sclerosis diagnosis underscores need for urgent research and awareness boost, report find
 
Delayed multiple sclerosis diagnosis underscores need for urgent research and awareness boost, report findA new report from MS Australia reveals that the average time to diagnose multiple sclerosis is nearly four years, highlighting the urgent need for increased research investment and enhanced awareness.
 
 
 New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial
 
New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trialA recent study in Nature Medicine found that LM11A-31, targeting the p75 neurotrophin receptor, is safe and shows promise in slowing Alzheimer's disease progression. The trial indicated significant biomarker improvements and potential benefits for further clinical investigation.
 
 
 Scientists identify genetic cause of rare, life-threatening immunodeficiency disorders in children
 
Scientists identify genetic cause of rare, life-threatening immunodeficiency disorders in childrenScientists have pinpointed genetic changes that can leave children born with little to no immune defence against infection.
 
 
 The prediabetes paradox: Balancing early intervention and overdiagnosis
 
The prediabetes paradox: Balancing early intervention and overdiagnosisPrediabetes, a diagnosis intended to identify high-risk persons and prevent progression to diabetes, has been a topic of ongoing debate, and experts continue to disagree about its screening criteria, interpretation, and implications.
 
 
    MediKnowledge - Your new AI assistant for trusted Medical Knowledge - is now live in the GPT Store.MediKnowledge - Your new AI assistant for trusted Medical Knowledge - is now live in the GPT Store.
 

Use this GPT to search for edited and trustworthy references, articles, and equipment reviews from over 20 years of trusted medical and healthcare content.

Currently only available to ChatGPT Plus account holders.

 
Ask a Question Now
 
 
 

How would you rate today's newsletter?